title: In reply.
authors.affiliation: Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
authors.forename: Binghe
authors.initials: B
authors.lastname: Xu
authors.affiliation: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
authors.forename: Andrew
authors.initials: A
authors.lastname: Seidman
authors.affiliation: Nottingham University Hospital, Nottingham, United Kingdom.
authors.forename: Stephen
authors.initials: S
authors.lastname: Chan
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D003841:Deoxycytidine / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives*; D006801:Humans; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D043823:Taxoids; D003841:Deoxycytidine; D005472:Fluorouracil